Non-GLP-1 RA anti-diabetic medicines included thiazolidinediones, sulfonylureas, metformin, insulin, and inhibitors of sodium-glucose transport protein 2, dipeptidyl peptidase 4, or -glucosidase
Insurance coverage varies considerably and often depends on whether the prescription is for diabetes or weight loss
The reason liquid formulations have shorter shelf lives relates to the nature of peptides in solution
"A proper diet, conservative timetable for weight loss, and plan for exercise are essential when taking this medication." CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER When contacted by Fox News Digital, Novo Nordisk maker of Ozempic and Wegovy confirmed that hair loss is an identified risk for semaglutide, and is listed as a side effect in the product information
That said, you arent simply stuck with the discomfort